Computational deconvolution of cell type-specific gene expression in COPD and IPF lungs reveals disease severity associations
Go back to Resources
Computational deconvolution of cell type-specific gene expression in COPD and IPF lungs reveals disease severity associations
Authors:
Volume:
Issue:
Journal:
PMID:
Keywords:
Abstract:
Metabolomic profiling reveals distinct and shared biology in COPD and IPF
Go back to Resources
Metabolomic profiling reveals distinct and shared biology in COPD and IPF
Authors:
Volume:
Issue:
Journal:
PMID:
Keywords:
Abstract:
In Vivo Human Cone Photoreceptor Inner Segment Diameter Database Using Adaptive Optics Retinal Imaging
Go back to Resources
In Vivo Human Cone Photoreceptor Inner Segment Diameter Database Using Adaptive Optics Retinal Imaging
Authors:
Volume:
Issue:
Journal:
PMID:
Keywords:
Abstract:
The Emmes Group Appoints Dr. Rama Kondru as Chief Executive Officer
Go back to Newsroom
The Emmes Group Appoints Dr. Rama Kondru as Chief Executive Officer
The Emmes Group Appoints Dr. Rama Kondru as Chief Executive Officer
ROCKVILLE, Maryland- The Emmes Group today announced that its Board of Directors has appointed Dr. Rama Kondru as Chief Executive Officer, reflecting the company's commitment to advancing next-generation clinical trials that improve quality, speed, and patient outcomes.
This appointment reflects the Board's confidence in Dr. Kondru's ability to drive innovation and operational excellence and underscores its commitment to advancing clinical research through scientific excellence, technology, and artificial intelligence.
Download Go back to Newsroom
ROCKVILLE, Maryland- The Emmes Group today announced that its Board of Directors has appointed Dr. Rama Kondru as Chief Executive Officer, reflecting the company's commitment to advancing next-generation clinical trials that improve quality, speed, and patient outcomes.
This appointment reflects the Board's confidence in Dr. Kondru's ability to drive innovation and operational excellence and underscores its commitment to advancing clinical research through scientific excellence, technology, and artificial intelligence.
Transcriptomic and proteomic signatures following AS03-adjuvanted Influenza A/H7N9 vaccine
Go back to Resources
Transcriptomic and proteomic signatures following AS03-adjuvanted Influenza A/H7N9 vaccine
Authors:
Volume:
Journal:
Keywords:
Abstract:
The brain as an HIV reservoir: Recent findings using autopsy tissues from people with HIV
Go back to Resources
The brain as an HIV reservoir: Recent findings using autopsy tissues from people with HIV
Authors:
Volume:
Issue:
Journal:
PMID:
Keywords:
Abstract:
Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial
Go back to Resources
Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial
Authors:
Journal:
PMID:
Keywords:
Abstract:
Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial
Go back to Resources
Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial
Authors:
Journal:
PMID:
Keywords:
Abstract:
Collaborative care intervention for risky opioid use among primary care patients: The STOP randomized clinical trial
Go back to Resources
Collaborative care intervention for risky opioid use among primary care patients: The STOP randomized clinical trial
Authors:
Journal:
PMID:
Keywords:
Abstract: